학술논문
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
Document Type
Article
Author
Wu, Chun-Ying; Lee, Yi-Chia; Tseng, Ping-Huei; Wu, Jeng-Yih; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun; Liou, Jyh-Ming ; Jiang, Xiao-Tao ; Chen, Chieh-Chang; Luo, Jiing-Chyuan; Bair, Ming-Jong; Chen, Po-Yueh; Chou, Chu-Kuang; Fang, Yu-Jen; Chen, Mei-Jyh; Chen, Chien-Chuan; Lee, Ji-Yuh; Yang, Tsung-Hua; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chen, Chi-Yi; Shun, Chia-Tung; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; Tseng, Cheng-Hao; Chang, Chi-Yang; Lin, Jaw-Town; El-Omar, Emad M; Wu, Ming-Shiang
Source
In The Lancet Gastroenterology & Hepatology March 2023 8(3):228-241
Subject
Language
ISSN
2468-1253